In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 24th, 2009 | 21 | Yes |
Popular Name: (4-methoxyphenyl)BLAHol (4-methoxyphenyl)BLAHol
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.57 | 7.05 | -10.93 | 1 | 4 | 0 | 55 | 298.367 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDN1A-1-E | CDK-interacting Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.37 | Functional ≤ 10μM |
Z80120-1-O | DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 290 | 0.44 | Functional ≤ 10μM |
Z80166-1-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other | Other | 330 | 0.43 | Functional ≤ 10μM |
Z80211-1-O | LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 150 | 0.45 | Functional ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 2400 | 0.37 | Functional ≤ 10μM |
Z81331-1-O | SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other | Other | 230 | 0.44 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDN1A_HUMAN | P38936 | CDK-interacting Protein 1, Human | 2400 | 0.37 | Functional ≤ 10μM |
Z80120 | Z80120 | DLD-1 (Colon Adenocarcinoma Cells) | 290 | 0.44 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 2400 | 0.37 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 330 | 0.43 | Functional ≤ 10μM |
Z80211 | Z80211 | LoVo (Colon Adenocarcinoma Cells) | 150 | 0.45 | Functional ≤ 10μM |
Z81331 | Z81331 | SW-620 (Colon Adenocarcinoma Cells) | 230 | 0.44 | Functional ≤ 10μM |
Description | Species |
---|---|
AKT phosphorylates targets in the cytosol | |
Constitutive PI3K/AKT Signaling in Cancer | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Transcriptional activation of cell cycle inhibitor p21 |
No pre-computed analogs available. Try a structural similarity search.